Lisata Therapeutics Inc (LSTA)
2.77
-0.04
(-1.60%)
USD |
NASDAQ |
May 17, 16:00
2.76
-0.01
(-0.36%)
After-Hours: 20:00
Lisata Therapeutics Total Liabilities (Quarterly): 5.497M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 5.497M |
December 31, 2023 | 6.80M |
September 30, 2023 | 5.385M |
June 30, 2023 | 4.651M |
March 31, 2023 | 5.623M |
December 31, 2022 | 6.71M |
September 30, 2022 | 6.758M |
June 30, 2022 | 3.74M |
March 31, 2022 | 3.222M |
December 31, 2021 | 5.008M |
September 30, 2021 | 4.125M |
June 30, 2021 | 3.935M |
March 31, 2021 | 4.593M |
December 31, 2020 | 3.76M |
September 30, 2020 | 4.532M |
June 30, 2020 | 3.925M |
March 31, 2020 | 5.156M |
December 31, 2019 | 6.60M |
September 30, 2019 | 6.689M |
June 30, 2019 | 6.728M |
March 31, 2019 | 6.83M |
December 31, 2018 | 7.126M |
September 30, 2018 | 7.044M |
June 30, 2018 | 8.626M |
March 31, 2018 | 11.40M |
Date | Value |
---|---|
December 31, 2017 | 13.19M |
September 30, 2017 | 14.57M |
June 30, 2017 | 18.21M |
March 31, 2017 | 50.50M |
December 31, 2016 | 49.45M |
September 30, 2016 | 47.29M |
June 30, 2016 | 51.08M |
March 31, 2016 | 50.00M |
December 31, 2015 | 33.92M |
September 30, 2015 | 64.71M |
June 30, 2015 | 62.67M |
March 31, 2015 | 68.85M |
December 31, 2014 | 68.20M |
September 30, 2014 | 69.28M |
June 30, 2014 | 56.10M |
March 31, 2014 | 27.33M |
December 31, 2013 | 27.79M |
September 30, 2013 | 22.65M |
June 30, 2013 | 20.62M |
March 31, 2013 | 20.89M |
December 31, 2012 | 21.59M |
September 30, 2012 | 75.10M |
June 30, 2012 | 86.17M |
March 31, 2012 | 85.51M |
December 31, 2011 | 75.20M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
3.222M
Minimum
Mar 2022
6.80M
Maximum
Dec 2023
5.172M
Average
5.082M
Median
Total Liabilities (Quarterly) Benchmarks
Becton Dickinson & Co | 28.51B |
Edwards Lifesciences Corp | 2.550B |
AIM ImmunoTech Inc | 9.147M |
Protalix BioTherapeutics Inc | 60.04M |
Armata Pharmaceuticals Inc | 176.87M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 48.24M |
Shareholders Equity (Quarterly) | 43.00M |